-
1
-
-
33644607018
-
Medical progress: Multiple sclerosis - The plaque and its pathogenesis
-
DOI 10.1056/NEJMra052130
-
Frohman EM, Racke MK, Raine CS. Multiple sclerosis: the plaque and its pathogenesis. N Engl J Med. 2006;354(9):942-955. (Pubitemid 43313661)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.9
, pp. 942-955
-
-
Frohman, E.M.1
Racke, M.K.2
Raine, C.S.3
-
2
-
-
0026506799
-
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin
-
Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature. 1992;356(6364):63-66.
-
(1992)
Nature
, vol.356
, Issue.6364
, pp. 63-66
-
-
Yednock, T.A.1
Cannon, C.2
Fritz, L.C.3
Sanchez-Madrid, F.4
Steinman, L.5
Karin, N.6
-
3
-
-
33644584352
-
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
-
AFFIRM Investigators
-
Polman CH, O'Connor PW, Havrdova E, et al; AFFIRM Investigators. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006;354(9):899-910.
-
(2006)
N Engl J Med
, vol.354
, Issue.9
, pp. 899-910
-
-
Polman, C.H.1
O'Connor, P.W.2
Havrdova, E.3
-
4
-
-
33646347610
-
Immune surveillance in multiple sclerosis patients treated with natalizumab
-
DOI 10.1002/ana.20858
-
Stüve O, Marra CM, Jerome KR, et al. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann Neurol. 2006;59(5):743-747. (Pubitemid 43673151)
-
(2006)
Annals of Neurology
, vol.59
, Issue.5
, pp. 743-747
-
-
Stuve, O.1
Marra, C.M.2
Jerome, K.R.3
Cook, L.4
Cravens, P.D.5
Cepok, S.6
Frohman, E.M.7
Phillips, T.8
Arendt, G.9
Hemmer, B.10
Monson, N.L.11
Racke, M.K.12
-
5
-
-
70449525704
-
Chemokines and chemokine receptors: Standing at the crossroads of immunobiology and neurobiology
-
Ransohoff RM. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity. 2009;31(5):711-721.
-
(2009)
Immunity
, vol.31
, Issue.5
, pp. 711-721
-
-
Ransohoff, R.M.1
-
6
-
-
2142730100
-
Central memory and effector memory T cell subsets: Function, generation, and maintenance
-
DOI 10.1146/annurev.immunol.22.012703.104702
-
Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745-763. (Pubitemid 38680440)
-
(2004)
Annual Review of Immunology
, vol.22
, pp. 745-763
-
-
Sallusto, F.1
Geginat, J.2
Lanzavecchia, A.3
-
7
-
-
0037077308
-
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
-
DOI 10.1074/jbc.C200176200
-
Brinkmann V, Davis MD, Heise CE, et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem. 2002;277(24):21453- 21457. (Pubitemid 34952287)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.24
, pp. 21453-21457
-
-
Brinkmann, V.1
Davis, M.D.2
Heise, C.E.3
Albert, R.4
Cottens, S.5
Hof, R.6
Bruns, C.7
Prieschl, E.8
Baumruker, T.9
Hiestand, P.10
Foster, C.A.11
Zollinger, M.12
Lynch, K.R.13
-
8
-
-
76149093586
-
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis
-
FREEDOMS Study Group
-
Kappos L, Radue EW, O'Connor P, et al; FREEDOMS Study Group. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med. 2010;362(5):387-401.
-
(2010)
N Engl J Med
, vol.362
, Issue.5
, pp. 387-401
-
-
Kappos, L.1
Radue, E.W.2
O'Connor, P.3
-
10
-
-
53049085954
-
Central nervous system-directed effects of FTY720 (fingolimod)
-
Miron VE, Schubart A, Antel JP. Central nervous system-directed effects of FTY720 (fingolimod). J Neurol Sci. 2008;274(1-2):13-17.
-
(2008)
J Neurol Sci
, vol.274
, Issue.1-2
, pp. 13-17
-
-
Miron, V.E.1
Schubart, A.2
Antel, J.P.3
|